RxDoctor Payments Data

Hilary English

Family · Springfield, MONPI 1083366033

Payments from drug & device makers

$2,605in general payments, 2019–2025

Across 149 payments — averaging $17.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$347
  • Novo Nordisk$314
  • AbbVie$278
  • Lilly USA, LLC$177
  • Neurocrine Biosciences, Inc.$136
  • Pfizer$135
  • plus $1K from 26 others

What the payments were for

  • Food & beverage$2,605100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,605 in reported general payments places this provider in the 80th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$967
Medicare patients
11
Services billed
20

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide88$112,899
EliquisApixaban86$106,389
JardianceEmpagliflozin82$99,786
OzempicSemaglutide74$95,712
FarxigaDapagliflozin Propanediol66$80,186
XareltoRivaroxaban22$32,590
JanuviaSitagliptin Phosphate28$23,999
EntrestoSacubitril/Valsartan14$12,386
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr18$11,001
SymbicortBudesonide/Formoterol Fumarate20$9,422
Lantus SolostarInsulin Glargine,hum.Rec.Anlog37$4,839
Levothyroxine Sodium488$3,913
VascepaIcosapent Ethyl11$3,811
Rosuvastatin Calcium363$3,654
ArexvyRsvpref3 Antigen/As01e/Pf13$3,209

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$177$112,89988 claims
PfizerEliquis$135$106,38986 claims
Boehringer IngelheimJardiance$50$99,78682 claims
Novo NordiskOzempic$314$95,71274 claims
AstraZenecaFarxiga, Symbicort$123$89,60986 claims
MerckJanuvia$34$23,99928 claims
GSKAnoro Ellipta, Arexvy$29$14,21031 claims
NovartisEntresto$91$12,38614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,812 family providers in Missouri.

Other family in Springfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →